Rennova Health, Inc. (NASDAQ:RNVA) Files An 8-K Other Events
Item 8.01.
| Other Events. |
On May 18, 2017, the Company issued a press release announcing
the postponment of its Special Meeting of Stockholders from May
19, 2017 to May 26, 2017. A copy of the press release is attached
hereto as Exhibit 99.1, and is incorporated by reference herein.
| Item 9.01. | Financial Statements and Exhibits. |
(d)Exhibits
| Exhibit No. | Exhibit Description |
| 99.1 | Press Release dated May 18, 2017 |
About Rennova Health, Inc. (NASDAQ:RNVA)
Rennova Health, Inc. (Rennova), formerly CollabRx, Inc., is a provider of diagnostics and supportive software solutions to healthcare providers. The Company operates in three segments: clinical laboratory operations, supportive software solutions, and decision support and informatics operations. The Company is a healthcare enterprise that delivers products and services, including laboratory diagnostics, healthcare technology solutions, and revenue cycle management and intends to provide financial services, to medical providers. Rennova’s principal line of business is clinical laboratory blood and urine testing services. It is also engaged in the provision of urine drug toxicology testing to physicians, clinics and rehabilitation facilities in the United States. Its clinical laboratories include Biohealth Medical Laboratory, Inc.; Alethea Laboratories, Inc.; International Technologies, LLC; EPIC Reference Labs, Inc., and Epinex Diagnostics Laboratories, Inc. Rennova Health, Inc. (NASDAQ:RNVA) Recent Trading Information
Rennova Health, Inc. (NASDAQ:RNVA) closed its last trading session 00.000 at 0.660 with 184,512 shares trading hands.